Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Willing and able to travel to the qigong sessions to participate in person in Sacramento, CA.
English-speaking adults age 18 or greater
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Study Summary
This trial will test if qigong can help improve health and quality of life for long-term COVID-19 symptom sufferers.
Who is the study for?
This trial is for English-speaking adults over 18 who had COVID-19 and are still feeling sick after 12 weeks. They must be able to use the internet, fill out forms, and travel to Sacramento, CA for qigong sessions. People with lung damage from COVID-19, dementia or other conditions that make it hard to participate fully can't join.Check my eligibility
What is being tested?
The study is testing if external qigong can improve life quality for people with long-term symptoms from COVID-19. Participants will attend qigong sessions in person and their health changes will be tracked through questionnaires.See study design
What are the potential side effects?
Since this trial involves a non-invasive practice like qigong, which includes gentle movements and meditation, no significant side effects are expected. However, individual experiences may vary.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can travel to Sacramento, CA for qigong sessions.
Select...
I am 18 or older and speak English.
Select...
I have had COVID-19 symptoms for more than 12 weeks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in physical health
Trial Design
2Treatment groups
Experimental Treatment
Group I: Waitlist ControlExperimental Treatment1 Intervention
Receives 6 sessions of qigong after the immediate group
Group II: ImmediateExperimental Treatment1 Intervention
Receives 6 sessions of qigong first.
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
909 Previous Clinical Trials
4,704,082 Total Patients Enrolled
8 Trials studying COVID-19
7,293 Patients Enrolled for COVID-19
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have lung scarring from COVID-19, shown by tests or breathing tests showing less than 80% normal lung function.I can travel to Sacramento, CA for qigong sessions.I am 18 or older and speak English.You have dementia.I have had COVID-19 symptoms for more than 12 weeks.You have a condition that makes it hard for you to fill out surveys or go to qigong sessions.
Research Study Groups:
This trial has the following groups:- Group 1: Immediate
- Group 2: Waitlist Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Approximately how many volunteers are enrolled in this research trial?
"Affirmative, the information hosted on clinicaltrials.gov attests that this experiment is presently seeking suitable candidates. It was originally put forward on April 1st 2023 and last updated accordingly. 48 individuals need to be identified from one establishment for enrolment in the trial."
Answered by AI
Are there any open opportunities to participate in this clinical trial?
"Affirmative. Clinicaltrials.gov provides evidence that this medical experiment, which was initially released on April 1st 2023, is presently recruiting. The trial requires 48 participants to be sourced from one location."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger